The primary function of the bronchial epithelium is to act as a defensive barrier aiding the maintenance of normal airway function. Bronchial epithelial cells (BECs) form the interface between the external environment and the internal milieu, making it a major target of inhaled insults. However, BECs can also serve as effectors to initiate and orchestrate immune and inflammatory responses by releasing chemokines and cytokines, which recruit and activate inflammatory cells. They also produce excess reactive oxygen species as a result of an oxidant/antioxidant imbalance which contributes to chronic pulmonary inflammation and lung tissue damage. Accumulated mucus from hyperplastic BECs obstructs the lumen of small airways, whereas impaired cell repair, squamous metaplasia and increased extracellular matrix deposition underlying the epithelium is associated with airway remodelling particularly fibrosis and thickening of the airway wall. These alterations in small airway structure lead to airflow limitation, which is critical in the clinical diagnosis of chronic obstructive pulmonary disease (COPD). In this review, we discuss the abnormal function of BECs within a disturbed immune homeostatic environment consisting of ongoing inflammation, oxidative stress and small airway obstruction.
Introduction
Chronic obstructive pulmonary disease (COPD) represents a syndrome comprising chronic bronchitis (CB) and emphysema characterised by largely irreversible and progressive airflow limitation [1] . More than 200 million people worldwide are currently affected by the disease, which is the fourth leading cause of death worldwide [2] and is projected to be the third leading cause by 2030 [3] . At the pathological level, COPD is associated with chronic pulmonary inflammation in response to environmental insults. This is, in turn, inextricably linked to disturbed tissue repair, increased mucus secretion and epithelial cell hyperplasia with airway wall thickening in the small conducting airways [4] . Bronchial epithelial cells (BECs), which line the airway lumen, are among the first sites of contact for environmental stimuli (microorganisms, gases and allergens) and perform a crucial role in maintaining normal airway function. Studies on human bronchial biopsies in COPD have demonstrated increased inflammatory gene and protein expression and structural alterations in bronchial epithelial cells [5] [6] [7] [8] suggesting a causal role of BECs in COPD pathogenesis.
Bronchial epithelial cells (BECs)
BECs are composed of various cell types and may be classified into three categories based on ultrastructural, functional and biochemical criteria: basal, ciliated and secretory cells [9] . Basal cells are ubiquitous in the large (50%) and small airways (81%) [10] but the absolute cell count decreases with airway size [11] . Basal epithelial cells exclusively express hemidesmosomes indicating an important role in the attachment of themselves and more superficial cells to the basement membrane [11, 12] . These cells are also thought to be primary progenitor or stem cells because they can self-renew and give rise to secretory and ciliated epithelial cells in response to epithelial injury [13] . In addition to their structural and progenitor functions, basal epithelial cells also produce various bioactive molecules, including neutral endopeptidase, 15-lipoxygenase products and cytokines [14] .
Ciliated epithelial cells are the major cell type within the airways, accounting for over 50% of all epithelial cells [9] . They possess up to 300 cilia per cell and have numerous energy-producing mitochondria adjacent to their apical surface, highlighting the critical function of the cells in clearing mucus out from the airways via directional ciliary beating [15] .
Mucus (goblet) cells are large secretory granules containing large quantities of mucin glycoproteins which secrete mucus in order to trap foreign objects in the airway lumen [16] . A balance between the correct amount of mucus production and clearance provides a critical defensive barrier and prevents airway surface desiccation [17] .
Mucus cells are also capable of self-renewal and differentiation into ciliated epithelial cells [11] .
In humans, non-ciliated secretory cells called Club cells (these were formerly known as Clara cells) exist in the small airways and trachea. Considering the critical functions of BECs in maintaining the normal structure and function of the airways it is not surprising that dysregulated BECs may contribute to the pathogenesis of many lung diseases such as COPD. In this review we address the evidence for a critical role of dysfunctional BECs in the pathogenesis of COPD.
BECs initiate and regulate immune responses
The lungs are persistently exposed to environmental insults, but rarely show signs of infection, implying the existence of effective host defence mechanisms. The host is protected against various stimuli by a multi-layered defence system consisting of a combination of physical barriers, as well as innate and adaptive immune mechanisms 
BECs act as both targets and potent effector cells in chronic pulmonary inflammation
Chronic inflammation contributes to airflow limitation in COPD [1, 49] should also be improved without the need for separate therapies. BECs are exposed to exogenous oxidants, such as CS, which induces production of ROS and depletion of some antioxidants. Excessive ROS production overwhelms the antioxidant defense mechanisms in the airways resulting in elevated expression of inflammatory mediators. This, in turn, induces an influx of inflammatory cells into the airway and lung. In addition, excess oxidative stress impairs the structural integrity of BECs and the protective capacity of the bronchial epithelium against inhaled oxidants, further enhancing the inflammation.
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